REGEN BIOPHARMA, INC. (RGBP) Net margin 2016–2025
REGEN BIOPHARMA, INC. (RGBP) net profit margin by fiscal year — reported net income divided by reported revenue.
-538.8%FY2025 · since FY2016: -7750.6% → -538.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -538.8% | -256.3 pp |
| FY2024 | -282.5% | -771.4 pp |
| FY2023 | 488.9% | -1457.9 pp |
| FY2022 | 1946.8% | +13002.2 pp |
| FY2021 | -11055.4% | -14159.4 pp |
| FY2020 | 3104.0% | +5488.7 pp |
| FY2019 | -2384.7% | +2330.5 pp |
| FY2018 | -4715.2% | +593.0 pp |
| FY2017 | -5308.2% | +2442.4 pp |
| FY2016 | -7750.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice